Paraneoplastic Opsoclonus-Myoclonus-Ataxia (OMA) syndrome in an adult patient with esthesioneuroblastoma.
Van Diest
Dominique
D
De Raeve
Hendrik
H
Claes
Jozef
J
Parizel
Paul M
PM
De Ridder
Dirk
D
Cras
Patrick
P
D014408:Biomarkers, Tumor / Q000032:analysis / Q000378:metabolism; D002524:Cerebellar Ataxia / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D002531:Cerebellum / Q000187:drug effects / Q000276:immunology / Q000503:physiopathology; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D018304:Esthesioneuroblastoma, Olfactory / Q000150:complications* / Q000276:immunology / Q000473:pathology*; D005005:Ethmoid Sinus / Q000276:immunology / Q000473:pathology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D009300:Nasal Septum / Q000276:immunology / Q000473:pathology; D009801:Oculomotor Muscles / Q000187:drug effects / Q000276:immunology / Q000503:physiopathology; D053578:Opsoclonus-Myoclonus Syndrome / Q000209:etiology* / Q000276:immunology* / Q000628:therapy; D010255:Paranasal Sinus Neoplasms / Q000150:complications* / Q000276:immunology / Q000473:pathology*; D012074:Remission Induction; D012878:Skin Neoplasms / Q000556:secondary / Q000601:surgery; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D007166:Immunosuppressive Agents; D008775:Methylprednisolone